|
|
Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage
Aurélie Fluckiger
,
Romain Daillere
,
Mohamed Sassi
,
Barbara S Sixt
,
Peng Liu
et al.
Journal articles
inserm-02923397v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Association of AXL and PD-L1 Expression with Clinical Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade
Stéphane Terry
,
Cécile Dalban
,
Nathalie Rioux-Leclercq
,
Julien Adam
,
Maxime Meylan
et al.
Journal articles
hal-03477307v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Phase II study of axitinib for downstaging cT2a to cT1 renal tumors for allowing partial nephrectomy (AXIPAN).
Jean-Jacques Patard
,
Jean-Christophe Bernard
,
Karim Bensalah
,
Hervé Baumert
,
Hervé Lang
et al.
Journal of Clinical Oncology, 2016, 34 (2)
Journal articles
hal-01361499v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Partial nephrectomy versus ablative therapy for the treatment of renal tumors in an imperative setting
Jean-Alexandre Long
,
Jean-Christophe Bernhard
,
Pierre Bigot
,
Cécilia Lanchon
,
Philippe Paparel
et al.
Journal articles
hal-01792768v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Renal Cell Carcinoma Programmed Death-ligand 1, a New Direct Target of Hypoxia-inducible Factor-2 Alpha, is Regulated by von Hippel-Lindau Gene Mutation Status
Yosra Messai
,
Sophie Gad
,
Muhammad Zaeem Noman
,
Gwenael Le Teuff
,
Sophie Couve
et al.
Journal articles
hal-01255838v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
MET is a potential target across all papillary renal cell carcinomas: result from a large molecular study of pRCC with CGH array and matching gene expression array
Laurence Albiges
,
Justine Guegan
,
Audrey Le Formal
,
Virginie Verkarre
,
Nathalie Rioux-Leclercq
et al.
Journal articles
hal-01064619v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Chemotherapy in hormone-sensitive metastatic prostate cancer: Evidences and uncertainties from the literature
Gwenaëlle Gravis
,
François Audenet
,
Jacques Irani
,
Marc-Olivier Timsit
,
Philippe Barthélémy
et al.
Journal articles
hal-01632557v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Axitinib in first-line for patients with metastatic papillary renal cell carcinoma: Results of the multicentre, open-label, single-arm, phase II AXIPAP trial
Sylvie Négrier
,
Nathalie Rioux-Leclercq
,
Céline Ferlay
,
Marine Gross-Goupil
,
Gwénaelle Gravis
et al.
Journal articles
hal-02552562v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Everolimus or sunitinib as first-line treatment of metastatic papillary renal cell carcinoma: A retrospective study of the GETUG group (Groupe d'Etude des Tumeurs Uro-Genitales)
Mathilde Cancel
,
Gaelle Fromont
,
Cyriac Blonz
,
Christine Chevreau
,
Nathalie Rioux-Leclercq
et al.
Journal articles
hal-03476711v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Application of Machine Learning Models to Predict Recurrence After Surgical Resection of Nonmetastatic Renal Cell Carcinoma
Zine-Eddine Khene
,
Pierre Bigot
,
Nicolas Doumerc
,
Idir Ouzaid
,
R. Boissier
et al.
Journal articles
hal-03775987v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|